Moreover, CD34, CD45, CD99, HLA-DR, Terminal deoxynucleotidyl transferase (TdT), and CD38 are commonly used as progenitor markers for diagnosing and classifying AML (Weir and Borowitz, 2001, Peters and Ansari, 2011). This evidence concerns the gene CD38 and acute myeloid leukemia.